Author: Golden R.J. Holm S.E. Robinson D.E. Julkunen P.H. Reese E.A.
Publisher: Academic Press
ISSN: 0273-2300
Source: Regulatory Toxicology and Pharmacology, Vol.26, Iss.2, 1997-10, pp. : 142-155
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Benefit-Risk Assessment of Irinotecan in Advanced Colorectal Cancer
Drug Safety, Vol. 28, Iss. 5, 2005-01 ,pp. :
Benefit-Risk Assessment of Bevacizumab in the Treatment of Breast Cancer
Drug Safety, Vol. 35, Iss. 1, 2012-01 ,pp. :
Biomarkers for Risk Assessment and Prevention of Breast Cancer
Current Cancer Drug Targets, Vol. 9, Iss. 4, 2009-06 ,pp. :